🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. Does a 91-day self-talk journal intervention improve outcomes of self-cr...
Status
Completed
Location
Behavioural Medicine Lab UVic
Start Date
2022-09-13
Trial ID
NCT05738109
Treatments Being Tested
The objective of this study is to assess the effect of preoperative adminis...
Status
Completed
Location
University of Vermont Medical Center
Start Date
2015-03-10
Trial ID
NCT02405832
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc i...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-01
Trial ID
NCT01756521
Treatments Being Tested
This study was conducted to determine the efficacy and safety of GWP42003 c...
Status
Completed
Location
Multiple Locations
Start Date
2012-05-09
Trial ID
NCT01562314
CTQJ230A1US13 is a randomized, double-blind, placebo-controlled, multicente...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07625306
Treatments Being Tested
This study will evaluate the percentage change from baseline in weight afte...
Status
Completed
Location
Handan First Hospital
Start Date
2024-08-14
Trial ID
NCT07020884
Treatments Being Tested
The objectives of the study are to assess the safety and tolerability of a ...
Status
Completed
Location
Ironwood Investigational Site
Start Date
2015-10
Trial ID
NCT02572349
Treatments Being Tested
The current available treatments for PTSD are not fully effective for cogni...
Status
Completed
Location
Ralph H. Johnson VA Medical Center, Charleston, SC
Start Date
2014-10-15
Trial ID
NCT02287038
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested